Efficacy and tolerability of 16% subcutaneous immunoglobulin compared with 20% subcutaneous immunoglobulin in primary antibody deficiency
2015 ◽
Vol 181
(3)
◽
pp. 441-450
◽
2008 ◽
Vol 101
(2)
◽
pp. 114-121
◽
1995 ◽
Vol 9
(2)
◽
pp. 94-94
2014 ◽
Vol 178
◽
pp. 146-148
◽
2020 ◽
Vol 40
(3)
◽
pp. 279-286
◽
2015 ◽
Vol 182
(1)
◽
pp. 51-56
◽
2000 ◽
Vol 105
(1)
◽
pp. S215
2008 ◽
Vol 28
(4)
◽
pp. 875-876
◽
Keyword(s):